Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics
Xuan Huang, Xiao‐Yong Zhang, Mengji Lu
Expert Opinion on Drug Discovery (2021) Vol. 16, Iss. 8, pp. 869-880
Closed Access | Times Cited: 23

Showing 23 citing articles:

Toll-like receptor 4 (TLR4): new insight immune and aging
Hyojin Kim, Hye-Min Kim, Jeong‐Hyung Lee, et al.
Immunity & Ageing (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 130
Natural killer cells: a promising immunotherapy for cancer
Junfeng Chu, Fengcai Gao, Meimei Yan, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 114
Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives
Haowei Sun, Yingmei Li, Peng Zhang, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 73
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56brightCD16−subset
Irene Veneziani, Claudia Alicata, Andrea Pelosi, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 1, pp. e003385-e003385
Open Access | Times Cited: 32
Chlorogenic acid alleviates crayfish allergy by altering the structure of crayfish tropomyosin and upregulating TLR8
Guirong Liu, Jiangzuo Luo, Wenwen Xiong, et al.
Food Chemistry (2024) Vol. 443, pp. 138614-138614
Open Access | Times Cited: 8
Accompaniment to the promotion of life projects of HIV-positive young people. A complex qualitative study
Daimara Barrera León, Raquel Yovana Tello Flores, Francisco Ramos Guzmán, et al.
Región Científica (2024)
Open Access | Times Cited: 8
Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor
Xiaoxiao Li, Ling Chen, Xiaobo Peng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 27
Toll‐Like Receptors in Pentachlorophenol‐ and Dibutyltin‐Induced Production of Pro‐Inflammatory Cytokines, Interleukin (IL)‐1β, and IL‐6, by Human Immune Cells
Aleshia Seaton‐Terry, Zachary R. Hunter, Meaghan M. Lewis, et al.
Journal of Applied Toxicology (2025) Vol. 45, Iss. 6, pp. 976-993
Closed Access
Proficiency of Pluronic Based Niosomes as an Effective Nano-carrier for the Formulation of Toll-Like Receptor-7/8 Agonists
Jyoti Rathee, Kushvinder Kumar, Aishwarya Keluskar, et al.
Journal of Drug Delivery Science and Technology (2025), pp. 106764-106764
Closed Access
Efflux-Enhanced Imidazoquinolines To Exploit Chemoresistance
Muhammad Haroon, Shireen Sultana, Seyedeh A. Najibi, et al.
ACS Omega (2025)
Open Access
Role of TLRs as signaling cascades to combat infectious diseases: a review
Md. Salauddin, Debaraj Bhattacharyya, Indranil Samanta, et al.
Cellular and Molecular Life Sciences (2025) Vol. 82, Iss. 1
Open Access
The immunostimulatory activity of Epimedium flavonoids involves toll-like receptor 7/8
Jingyu Wu, Yi Ou, Min Yao, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful
Izabela Szulc-Kiełbik, Michał Kiełbik
Experientia supplementum (2022), pp. 107-140
Closed Access | Times Cited: 13
Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapy
Irene Veneziani, Claudia Alicata, Lorenzo Moretta, et al.
Immunology Letters (2023) Vol. 261, pp. 13-16
Open Access | Times Cited: 7
Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy
Fang Li, Biao Song, Wei-Feng Zhou, et al.
Viral Immunology (2023) Vol. 36, Iss. 9, pp. 564-578
Closed Access | Times Cited: 7
TLR7 Activation of Macrophages by Imiquimod Inhibits HIV Infection through Modulation of Viral Entry Cellular Factors
Fengzhen Meng, Jinbiao Liu, Xu Wang, et al.
Biology (2021) Vol. 10, Iss. 7, pp. 661-661
Open Access | Times Cited: 15
Toll-like receptors: New targets for multiple myeloma treatment?
Olaia Akesolo, Berta Buey, Manuel Beltrán‐Visiedo, et al.
Biochemical Pharmacology (2022) Vol. 199, pp. 114992-114992
Open Access | Times Cited: 11
Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis
Zhou Tian, Baojian Hong, Jianzhong Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Enhanced Delivery of TLR7/8 Agonists by Metal–Organic Frameworks for Hepatitis B Virus Cure
Liyuan Wang, Guiqiang Zhang, Yang Sun, et al.
ACS Applied Materials & Interfaces (2022) Vol. 14, Iss. 41, pp. 46176-46187
Closed Access | Times Cited: 7
Structural Optimization and Biological Evaluation of Isoxazolo[5,4-d]pyrimidines as Selective Toll-Like Receptor 7 Agonists
Nika Strašek Benedik, Ana Dolšak, Urban Švajger, et al.
ACS Omega (2024) Vol. 9, Iss. 2, pp. 2362-2382
Open Access | Times Cited: 1
Hypoxia is correlated with the tumor immune microenvironment: Potential application of immunotherapy in bladder cancer
Haotian Chen, Yao Zhang, Xingyu Chen, et al.
Cancer Medicine (2023) Vol. 12, Iss. 24, pp. 22333-22353
Open Access | Times Cited: 3
Structure-Based Optimization of a Fragment-like TLR8 Binding Screening Hit to an In Vivo Efficacious TLR7/8 Antagonist
Claudia Betschart, Michael Faller, F. Zink, et al.
ACS Medicinal Chemistry Letters (2022) Vol. 13, Iss. 4, pp. 658-664
Open Access | Times Cited: 5
Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown
Frank Twum Aboagye, Lawrence Annison, Henry Kwadwo Hackman, et al.
Advances in Virology (2024) Vol. 2024, pp. 1-12
Open Access
Page 1

Scroll to top